Stocktoria

Envoy Medical, Inc. COCH

Envoy Medical, Inc. statistics & valuation

Net margin-9857.3%
FCF margin-7626.6%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-6718.60% -9469.00% -9242.20% -9857.30% 20212022202320242025
Gross margin (%)
20212022202320242025
Operating margin (%)
-3673.40% -5809.80% -8558.20% -9240.70% 20212022202320242025
Return on equity (%)
20212022202320242025
Shares outstanding
10.1M 18.6M 21.3M 23.3M 20212022202320242025
Net debt ($)
20212022202320242025
Share buybacks ($)
20212022202320242025
Return on assets (%)
-0.10% -623.00% -361.80% -180.20% -277.60% 20212022202320242025
Free cash flow margin (%)
-3807.20% -5457.00% -8412.90% -7626.60% 20212022202320242025
Debt / equity (×)
20212022202320242025
EPS ($)
-$1.57 -$2.54 -$1.49 -$1.23 20212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021
Operating margin-9240.7%-8558.2%-5809.8%-3673.4%
Net margin-9857.3%-9242.2%-9469.0%-6718.6%
FCF margin-7626.6%-8412.9%-5457.0%-3807.2%
Return on assets-277.6%-180.2%-361.8%-623.0%-0.1%
Return on equity195.4%110.4%1684.8%44.0%0.6%
Current ratio0.541.181.020.650.32

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.